Cargando…
Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells
BACKGROUND: Daunorubicin is a traditional chemotherapeutic agent that plays a pivotal role in leukemia therapy. However, the dose-related toxicity remains a considerable challenge. The apoptosis-regulating gene, PDCD5, is downregulated in various tumors, including leukemias, and may provide a potent...
Autores principales: | Zhou, Ya-Lan, Yao, Qiu-Mei, Zhou, Jiao, Chang, Yan, Li, Jin-Lan, Wang, Ya-Zhe, Wu, Hong-Ping, Chen, Yu-Hong, Liu, Yan-Rong, Huang, Xiao-Jun, Ruan, Guo-Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112794/ https://www.ncbi.nlm.nih.gov/pubmed/30197523 http://dx.doi.org/10.2147/OTT.S167868 |
Ejemplares similares
-
Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer
por: Nelson, Amy R, et al.
Publicado: (2009) -
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin
por: Rai, Yogesh, et al.
Publicado: (2019) -
Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011) -
Improved Survival of Leukemic Mice Treated with Sodium Caseinate in Combination with Daunorubicin without Toxicity
por: Aguiñiga-Sánchez, Itzen, et al.
Publicado: (2021) -
Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin
por: Mohammadi, Saeed, et al.
Publicado: (2017)